Studies have shown that a blockage of A3 receptor reduced viability and chemotherapy resistance in glioblastoma stem-like cancer cells [85], whereas, inhibition of PDE5 potentiated gemcitabine in pancreatic cancer cells [86]. The gene discussed is PDE5A; the disease is cancer.